| Trial ID: | L0903 |
| Source ID: | NCT02690792
|
| Associated Drug: |
Vitamin E
|
| Title: |
Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Healthy;NAFLD (Non-Alcoholic Fatty Liver Disease);NASH (Non-Alcoholic Steatohepatitis)
|
| Interventions: |
Other: NAFLD/NASH - Placebo;Dietary Supplement: NAFLD/NASH - Vitamin E
|
| Outcome Measures: |
Change in Measurement of percentage of Liver Fat by MRI;Change in Measurement of Insulin Sensitivity via Hyperinsulinemic glucose clamp;Change in Measurement of glucose metabolism turnover by non-radioactive isotopic infusion and recoverynan
|
| Sponsor/Collaborators: |
Jeffrey Browning
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
70
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
17/03/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02690792
|
